BMC Musculoskeletal Disorders Volume 9
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
 Research articleGlucosamine increases hyaluronic acid production in human osteoarthritic synovium explantsEJ Uitterlinden1 , JLM Koevoet1,2 , CF Verkoelen^ 3 , SMA Bierma-Zeinstra4 , H Jahr1 , H Weinans1 , JAN Verhaar1 and GJVM van Osch1,2  1Dept. of Orthopaedics, Erasmus MC, University Medical Centre Rotterdam, the Netherlands 2Dept. of Otorhinolaryngology, Erasmus MC, University Medical Centre Rotterdam, the Netherlands 3Dept. of Urology, Erasmus MC, University Medical Centre Rotterdam, the Netherlands 4Dept. of General Practice, Erasmus MC, University Medical Centre Rotterdam, the Netherlands author email corresponding author email^Deceased
BMC Musculoskeletal Disorders 2008,
9:120doi:10.1186/1471-2474-9-120
|
|
| Published: |
11 September 2008 |
Abstract
Background
Glucosamine (GlcN) used by patients with osteoarthritis was demonstrated to reduce pain, but the working mechanism is still not clear. Viscosupplementation with hyaluronic acid (HA) is also described to reduce pain in osteoarthritis. The synthesis of HA requires GlcN as one of its main building blocks. We therefore hypothesized that addition of GlcN might increase HA production by synovium tissue.
Methods
Human osteoarthritic synovium explants were obtained at total knee surgery and pre-cultured for 1 day. The experimental conditions consisted of a 2 days continuation of the culture with addition of N-Acetyl-glucosamine (GlcN-Ac; 5 mM), glucosamine-hydrochloride (GlcN-HCl; 0.5 and 5 mM), glucose (Gluc; 0.5 and 5 mM). Hereafter HA production was measured in culture medium supernatant using an enzyme-linked binding protein assay. Real time RT-PCR was performed for hyaluronic acid synthase (HAS) 1, 2 and 3 on RNA isolated from the explants.
Results
0.5 mM and 5 mM GlcN-HCl significantly increased HA production compared to control (approximately 2 – 4-fold), whereas GlcN-Ac had no significant effect. Addition of 5 mM Gluc also increased HA production (approximately 2-fold), but 0.5 mM Gluc did not. Gene expression of the HA forming enzymes HAS 1, 2 and 3 was not altered by the addition of GlcN or Gluc.
Conclusion
Our data suggest that exogenous GlcN can increase HA production by synovium tissue and is more effective at lower concentrations than Gluc. This might indicate that GlcN exerts its potential analgesic properties through stimulation of synovial HA production. |